Nā huahana

Manaʻo ʻia ka mākeke intermediates pharmaceutical e ulu ma kahi CAGR o kahi kokoke i 5.3% i ka wā wānana.

ʻO kekahi o nā mea e alakaʻi nei i ka ulu ʻana o ka mākeke e pili ana i ka piʻi ʻana o nā maʻi maʻi a me ka ulu ʻana o nā hana R&D a me nā hana i ka ʻoihana lāʻau.

ʻO nā maʻi like ʻole, ka nui o nā maʻi cardiovascular, nā maʻi infectious, ka maʻi diabetes a me nā pilikia pili i ka puʻupaʻa, he kiʻekiʻe ma ka honua holoʻokoʻa.No laila, i ka honua holoʻokoʻa, ʻo ka hoʻonui nui ʻana a me ke kaumaha o nā maʻi like ʻole i nā makahiki āpau ke koi nei i ka noi no ka hoʻomohala ʻana i ka lāʻau lapaʻau a me kāna mākeke.

Aia ka piʻi ʻana o ka hoʻohana ʻana i nā ʻenehana holomua e like me ke kiʻekiʻe-throughput, bioinformatics a me combinatorial chemistry e ʻike maikaʻi i nā moho lāʻau.Ua loli nui ka ʻike ʻana i ka lāʻau me ka hoʻomohala ʻana i nā ʻenehana hou, e kōkua ana i ke kaʻina hana e lilo i mea hoʻomaʻemaʻe, pololei a emi ʻole ka manawa.ʻO ka kānana kiʻekiʻe ʻo ia kekahi o nā ʻenehana ʻike lāʻau i hoʻohana nui ʻia ma muli o ka automation, multi-detector readers, imaging hardware and software.No laila, ua manaʻo ʻia ka hoʻohana ʻana i nā intermediates lāʻau lapaʻau e ulu mau ma muli o ka hoʻonui ʻana i nā hana R&D i ka ʻoihana lāʻau.

ʻO nā mea waena lāʻau lapaʻau nā lāʻau lapaʻau i hoʻohana ʻia e like me nā API no ka hana ʻana i nā API, a hiki nō hoʻi ke kuhikuhi i nā mea maka i hana ʻia i ka wā o ka synthesis o nā API, pono e hoʻololi hou i ka molecular a i ʻole ka hana ʻana e lilo i API.Hoʻomaʻemaʻe ʻia nā intermediates lāʻau lapaʻau me nā mea maka kiʻekiʻe a hoʻohana ʻia i kekahi mau ʻoihana ʻē aʻe e like me nā lāʻau lapaʻau a me nā mea hoʻonaninani.